Publication of Circular and Notice of EGM

11 November 2025

The Schiehallion Fund Limited

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

Publication of Circular and Notice of Extraordinary General Meeting

The Schiehallion Fund Limited (the "Company") has today published a circular (the "Circular") and notice of an extraordinary general meeting (the "EGM") in connection with the proposed amendments to the Company's articles of incorporation ("Existing Articles"), the proposed admission of the Company's ordinary shares of no par value in the capital of the Company ("Ordinary Shares") to the closed-ended investment funds category of the Financial Conduct Authority (the "CEIF Category") and to trading on the Main Market of the London Stock Exchange (together, "Admission") and the proposed approval of waiver of Rule 9 of the Takeover Code granted by the Takeover Panel (together the "Proposals").

Details of the Proposals

Amendments to the Existing Articles

At the time of the Company's initial public offering, a substantial number of Ordinary Shares were expected to be held by investors who are residents of the United States and consequently, to help reduce the risk of the Company losing its status as a "foreign private issuer" ("FPI"), Articles 82(2) to 82(4) of the Existing Articles impose limitations on the voting rights attaching to Ordinary Shares held by US Residents. Those limitations are designed to prevent US Residents from exercising 50 per cent. or more of the votes on any resolution to appoint or remove a Director (a "Director Resolution") using a "voting cramdown" mechanism. However, in order to be eligible for Admission to the CEIF Category, all Ordinary Shares must carry an equal number of votes on any shareholder vote and, as a result of the voting cramdown mechanism, the Ordinary Shares do not currently satisfy this eligibility requirement and, consequently, are not eligible for Admission.

In order to make the Ordinary Shares eligible for Admission, while also seeking to maintain the Company's status as an FPI, the Board is proposing to adopt new articles of association (the "New Articles") in place of the Existing Articles which will amend the voting structure under the Existing Articles by introducing a new special voting share of the Company (the "Class B Share") and removing the voting cramdown mechanism. Full details of the Class B Shares and certain other proposed amendments to the Existing Articles are set out in the Circular.

Investment policy

In order to be eligible for Admission, the Company is required to have a published investment policy that complies with the UK Listing Rules and has been approved by the FCA.

The investment policy proposed to be adopted by the Company will codify the Company's existing investment objective and strategy, to which it is substantially the same (while incorporating certain additional clarifications required to meet the eligibility requirements for Admission).

The full text of the investment policy proposed to be adopted by the Company is set out in the appendix.

Rule 9 Waiver

The City Code on Takeovers and Mergers (the "Code") applies to the Company. Under Rule 9 of the Code ("Rule 9"), if any person acquires an interest in Ordinary Shares which, when taken together with Ordinary Shares in which they and persons acting in concert with them are already interested, carry 30 per cent. or more of the voting rights in the Company, that person will normally be required to make a general offer in cash to all Shareholders at the highest price paid by them or any person acting in concert with them for an interest in such Ordinary Shares within the preceding 12 months. Rule 9 also provides that if any person, together with persons acting in concert with them, is interested in Ordinary Shares which, in the aggregate, carry not less than 30 per cent. of the voting rights in the Company but does not hold Ordinary Shares carrying more than 50 per cent. of such voting rights, and such person, or any person acting in concert with them, acquires an interest in any other Ordinary Shares which increases the percentage of Ordinary Shares in the Company in which they are interested, that person will normally be required to make a general offer in cash to all Shareholders at the highest price paid by them or any person acting in concert with them for an interest in such Ordinary Shares within the preceding 12 months.

Under Rule 37 of the Code ("Rule 37"), if the Company purchases Ordinary Shares, a resulting increase in the percentage of voting rights carried by the Ordinary Share holdings of any person or group of persons acting in concert will be treated as an acquisition for the purposes of Rule 9. A Shareholder who is neither a Director nor acting in concert with a Director will not normally incur an obligation to make an offer under Rule 9 in these circumstances.

However, where a Shareholder has acquired Ordinary Shares at a time when they had reason to believe that a purchase by the Company of the Ordinary Shares would take place, then an obligation to make a mandatory bid under Rule 9 may arise. Market purchases of Ordinary Shares by the Company, if any, could have implications under Rule 9 for Shareholders with significant shareholdings.

As explained above, the Company proposes, subject to Admission, to introduce the Class B Shares. Under the New Articles, if the number of Ordinary Shares held by US Residents crosses 35 per cent., the Class B Share would be attributed a specified number of voting rights in relation only to Director Resolutions. The precise number of voting rights to be so attributed shall be calculated in accordance with a formula set out in the New Articles and shall be such number of voting rights as would reduce the proportion of the total voting rights on Director Resolutions which may be exercised by US Residents to the threshold set out in the New Articles.

Therefore, in the event that the proportion of the Ordinary Shares held by US Residents is equal to or exceeds 50 per cent. (which, based on the Company's historical experience with its US shareholding percentage, is very unlikely), the proportion of voting rights attributed to the Class B Share in relation to Director Resolutions would equal or exceed 30 per cent.

The Panel has agreed that it will waive the obligation on the trustee (acting on behalf of the non-charitable purpose trust established under Guernsey law for the purpose of holding the Class B Share) (the "Trustee") to make a general offer that could otherwise arise as a result of the issue to the Trustee of the Class B Share (the "Rule 9 Waiver"), subject to the approval of the Shareholders (other than the Directors) on a poll at the EGM.

Change of tax residency to UK and introduction of sterling quote

Although not part of the Proposals, as also announced on 23 May 2025, the Company intends to change its tax residence from Guernsey to the UK and to become a UK investment trust company for UK tax purposes. The Company will apply for approval as a UK investment trust company with effect from 1 February 2026.

In conjunction with the Proposals the Company shall introduce an additional market quote for the Ordinary Shares which will be denominated in Sterling. There will be no changes to the legal form or nature of the Ordinary Shares nor to the reporting currency of the Company's financial statements (which will remain in US Dollars).

Benefits of the Proposals

The Proposals are expected to benefit the Company by broadening the appeal of the Ordinary Shares to a wider range of investors. Admission is expected to improve the Company's ability to market the Ordinary Shares to retail investors (where appropriate) and improve the liquidity in the Ordinary Shares as a result of having access to a potentially larger pool of capital.

Extraordinary General Meeting

The implementation of the Proposals is conditional on the Shareholders passing the Resolutions at the EGM. A Notice convening the EGM, to be held at the offices of Herbert Smith Freehills Kramer LLP, Exchange House, Primrose Street, London EC2A 2EG at 10.00 a.m. (London time) on 8 December 2025, is set out in the Circular.

Expected Timetable

Prior to Admission, the Company has complied and continues to comply on a voluntary basis with certain provisions of the UK Listing Rules ("UKLRs"). Following Admission the Company will be required to comply in full with the applicable provisions of the UKLRs, including in relation to transactions with related parties, financial reporting, contents of shareholder circulars and other continuing obligations.

Capitalised terms used but not defined in this announcement will have the same meaning as set out in the Circular.

For further information, please contact:

Appendix

Investment objective

The Company's investment objective is to generate capital growth for investors through making long-term minority investments in later stage private businesses that the Company considers to have transformational growth potential and to have the potential to become publicly traded.

Investment Policy

In making its initial investment in a business, the Company will seek to invest in private businesses which it considers have the potential to become admitted to trading on a public stock exchange. Those investments will typically take the form of equity or equity-related instruments (which may include, without limitation, preference shares, convertible debt instruments, equity-related and equity-linked notes and warrants) issued by investee companies.

The Company will only invest in private businesses that are considered to have some or all of the following features:

· the potential to grow revenue and earnings multiple fold over the long term;

· scalable business models that should enable those businesses to grow into their opportunity;

· robust competitive advantages;

· exceptional management teams;

· an entry price which significantly undervalues the long-term opportunity for the business; and

· an ambition and ability to become stand-alone public companies.

Investee companies may be from any sector and any geography. While there are no specific limits placed on exposure to any one sector, the Company will at all times seek to invest and manage the portfolio in a manner consistent with spreading investment risk.

With prior approval of the Board, the Company may permit the use of derivatives for the purpose of currency hedging, though it currently does not expect to do so. Save for this and for investments made using equity-related instruments as described above, the Company may not engage in derivative transactions for any purpose.

The Board does not intend to use structural gearing with a view to enhancing equity returns on investments. The Company may employ gearing on a short-term basis for the purpose of bridging investments and general working capital purposes. The Company may in aggregate borrow amounts equalling up to 10% of net asset value, calculated at the time of drawdown.

The Company is subject to the following investment restrictions:

· an investee company must be a private investee company at the time of the Company's initial investment in that investee company. The Company may, however, make subsequent investments in the investee company, even if the investee company has been admitted to trading on a public stock exchange in the period since the Company's initial investment;

· a private investee company must have a value of at least US$500 million at the time of the Company's initial investment in the private investee company. This restriction will not apply to the Company's subsequent investments in the investee company, if any;

· the Company may not make an initial investment in a private investee company which exceeds in value 10% (calculated at the time of investment) of the Company's most recently published net asset value (save to the extent that breach of this 10% limit is due to a change in the value of the Company's invested assets or currency fluctuations from the time of the Company's firm commitment to make the investment to the time of investment);

· the Company may not make any investment or follow-on investment in an investee company that would cause the value of the Company's holding in that investee company to exceed 19.9% (calculated at the time of investment or follow-on investment) of the Company's most recently published net asset value;

· the Company may not make any investment in an investee company that would cause the Company's holding in that investee company to exceed 20% (calculated at the time of investment) of the total issued share capital of the investee company; and

· the Company will not invest in other listed closed-ended investment funds.

A reference to the value of assets of the Company (including investee companies) in the restrictions above shall refer to the value as determined in accordance with the Company's valuation policy from time to time.

The Company does not currently expect the portfolio to be majority invested in public investee companies at any point in time, but it has not set a limit on the percentage of the portfolio which can be invested in public investee companies at a given time.

It is intended that the Company will be substantially invested. However, the Company may at any time hold overnight or term deposits or, pending investment in investee companies, invest in a range of cash-equivalent instruments such as US Treasury Bills or money market funds. There is no restriction on the amount of cash or cash-equivalent instruments that the Company may hold and, given the longer time period involved in identifying, analysing and agreeing investment terms in private businesses, the Company may from time to time hold significant amounts in cash or cash equivalents pending reinvestment.